Retinohepatoendocrinologic syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3087OMIM:268040
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Retinohepatoendocrinologic syndrome, also known as Edwards syndrome (not to be confused with Trisomy 18), or sometimes referred to as retinal-hepatic-endocrine syndrome, is an extremely rare inherited condition that affects multiple body systems at the same time. The three main areas involved are the eyes (retina), the liver (hepatic system), and the hormone-producing glands (endocrine system). Patients typically experience progressive vision problems due to changes in the retina, which is the light-sensing tissue at the back of the eye. Liver involvement can range from mild abnormalities in liver function tests to more significant liver disease. The endocrine problems may include diabetes mellitus, thyroid dysfunction, or other hormonal imbalances. Because this syndrome affects several organ systems, patients often need care from multiple specialists working together. The condition was first described in a small number of families, and very little published medical literature exists about it. Treatment is mainly supportive and focused on managing each individual symptom. There is currently no cure or specific targeted therapy for this syndrome. Regular monitoring of vision, liver function, and hormone levels is essential to catch and manage complications early.

Key symptoms:

Progressive vision lossRetinal degeneration (damage to the light-sensing layer of the eye)Abnormal liver functionLiver enlargementDiabetes or high blood sugarThyroid problemsHormonal imbalancesNight blindnessFatigueGrowth problems in childrenDelayed puberty

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Retinohepatoendocrinologic syndrome.

View clinical trials →

No actively recruiting trials found for Retinohepatoendocrinologic syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Retinohepatoendocrinologic syndrome community →

No specialists are currently listed for Retinohepatoendocrinologic syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Retinohepatoendocrinologic syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Retinohepatoendocrinologic syndromeForum →

No community posts yet. Be the first to share your experience with Retinohepatoendocrinologic syndrome.

Start the conversation →

Latest news about Retinohepatoendocrinologic syndrome

No recent news articles for Retinohepatoendocrinologic syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How will each of my affected organ systems be monitored over time?,What signs or symptoms should prompt me to seek urgent medical care?,Is genetic testing available that could help confirm the diagnosis or identify the cause?,Are there any clinical trials or research studies I could participate in?,What support services are available for progressive vision loss?,How should my diabetes or other hormonal issues be managed alongside my liver condition?,Should my family members be tested or screened for this condition?

Common questions about Retinohepatoendocrinologic syndrome

What is Retinohepatoendocrinologic syndrome?

Retinohepatoendocrinologic syndrome, also known as Edwards syndrome (not to be confused with Trisomy 18), or sometimes referred to as retinal-hepatic-endocrine syndrome, is an extremely rare inherited condition that affects multiple body systems at the same time. The three main areas involved are the eyes (retina), the liver (hepatic system), and the hormone-producing glands (endocrine system). Patients typically experience progressive vision problems due to changes in the retina, which is the light-sensing tissue at the back of the eye. Liver involvement can range from mild abnormalities in l

How is Retinohepatoendocrinologic syndrome inherited?

Retinohepatoendocrinologic syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Retinohepatoendocrinologic syndrome typically begin?

Typical onset of Retinohepatoendocrinologic syndrome is childhood. Age of onset can vary across affected individuals.